| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
32,462 |
4,574 |
$5.14M |
| H0038 |
Self-help/peer services, per 15 minutes |
19,641 |
4,123 |
$1.08M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15,825 |
6,087 |
$1.01M |
| 90837 |
Psychotherapy, 53 minutes with patient |
3,570 |
1,778 |
$447K |
| H2015 |
Comprehensive community support services, per 15 minutes |
2,175 |
781 |
$163K |
| 90791 |
Psychiatric diagnostic evaluation |
964 |
963 |
$130K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
516 |
509 |
$90K |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
224 |
222 |
$39K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
203 |
136 |
$25K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
204 |
179 |
$25K |
| 99205 |
Prolong outpt/office vis |
61 |
61 |
$12K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
165 |
152 |
$11K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
159 |
144 |
$10K |
| 99215 |
Prolong outpt/office vis |
14 |
14 |
$3K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
83 |
81 |
$2K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
41 |
13 |
$1K |